• LG 101506: RXR Signaling in TNBC Immunity

  2026-09-12

  Explore how LG 101506, an RXR modulator, can support hypothesis-driven studies connecting nuclear receptor biology with immune-checkpoint phenotypes in triple-negative breast cancer. This article translates RBMS1–PD-L1 findings into practical assay design while clearly separating established evidence from testable RXR research questions.

• Puromycin Aminonucleoside: From Injury to Insight

  2026-09-11

  Puromycin aminonucleoside is more than a nephrotoxic reagent: it is a controlled entry point into podocyte biology, glomerular barrier failure, and mechanism-resolved translational research. This article connects its renal injury phenotype with emerging evidence on lactylation-driven RNA regulation while clearly defining the limits of cross-domain interpretation.

• Biotin (Vitamin B7) for Assay Design

  2026-09-11

  Biotin (Vitamin B7) connects metabolic biochemistry with high-sensitivity affinity assays, but free biotin must be distinguished from activated labeling esters. This guide shows how to build reproducible workflows around Biotin, including protein biotinylation controls and DNA–STING assay designs inspired by shrimp antiviral research.

• MPS IVA Cartilage and Lysosomal Exocytosis

  2026-09-10

  A 2026 study in a zebrafish model of mucopolysaccharidosis type IVA links GALNS deficiency to enhanced lysosomal exocytosis, altered cathepsin activity, and reduced TGFβ/BMP signaling during cartilage development. The findings broaden disease mechanisms beyond macromolecular storage and provide a framework for separating lysosome-mediated secretion defects from downstream growth-factor and extracellular-matrix abnormalities.

• Propranolol: A Translational Assay Framework

  2026-09-10

  Propranolol is a non-selective β-adrenergic receptor blocker whose effects span cardiovascular regulation, neural excitability, and metabolism. This translational framework shows how to design more interpretable propranolol assays by separating receptor engagement, tissue context, exposure, and phenotype.

• Doxorubicin Hydrochloride: Dual-Use Assay Design

  2026-09-09

  Doxorubicin hydrochloride is a powerful tool for cancer chemotherapy research and cardiotoxicity studies. This guide presents a paired assay strategy that connects tumor-cell response with cardiac stress biology and translates recent ATF4–H2S findings into better experimental decisions.

• APEX2 Enables Efficient TERT Expression in hESCs

  2026-09-09

  This preprint identifies APEX2 as a DNA repair enzyme required for efficient TERT expression and telomerase activity in human embryonic stem cells, with related evidence in a melanoma cell line. Its central contribution is the link between APEX2 occupancy at damage-prone repetitive elements and regulation of gene expression, extending APEX2 biology beyond canonical repair functions.

• Triiodothyronine in Oligodendrocyte Editing Assays

  2026-09-08

  Triiodothyronine (T3) can serve as a controlled endocrine variable in oligodendrocyte gene-editing research. This article connects T3 assay design with the spatially concentrated cABE strategy for PLP1 correction while clearly separating established evidence from testable hypotheses.

• Vacuolin-1: Lysosomal Exocytosis Inhibitor

  2026-09-08

  Vacuolin-1 is a cell-permeable lysosomal exocytosis inhibitor for dissecting Ca2+-dependent lysosome–plasma membrane fusion. It supports β-hexosaminidase release assays, plasma membrane repair research, and lysosome-mediated membrane trafficking studies when interpreted with appropriate trafficking and viability controls.

• Pleuromutilin Binding at the Ribosomal PTC

  2026-09-07

  The 2006 study by Long and colleagues combined chemical footprinting with ribosomal mutant analysis to define how tiamulin, valnemulin, and related pleuromutilins interact with the bacterial peptidyl transferase center. Its central implication is that the conserved mutilin core anchors binding, whereas side-chain contacts help determine activity against altered ribosomal surfaces and may guide improved derivative design.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody Workflow

  2026-09-07

  Build sensitive fluorescence workflows for rabbit primary antibodies across immunofluorescence, flow cytometry, and tissue imaging. This guide translates a DON–lycopene intestinal-barrier study into practical assay controls, optimization steps, and troubleshooting decisions without treating a secondary antibody as a substitute for biological validation.

• Thermal Shift Assay for Bacterial Sensor Ligands

  2026-09-05

  This 2025 review explains how thermal shift assays identify ligands for bacterial sensor proteins, with emphasis on soluble ligand-binding domains, pH optimization, and orthogonal validation. Its main practical contribution is a reliability framework that distinguishes useful thermal transitions from false-positive and false-negative screening outcomes.

• Hyaluronic acid sodium salt in siRNA and ECM

  2026-09-04

  Hyaluronic acid sodium salt connects extracellular matrix modeling with targeted siRNA nanoparticle research, offering a practical route to study immune-cell behavior, tissue injury, and delivery performance. This guide translates a recent neutrophil-focused lung injury study into assay design, formulation workflows, and troubleshooting decisions for Sodium hyaluronate research use.

• 5-Azacytidine: Workflow for Cancer Models

  2026-09-04

  Build reproducible DNA methylation and cancer-cell workflows with 5-Azacytidine, from fresh stock preparation to demethylation, cytotoxicity, and dormancy readouts. A study-defined AZA–retinoic acid sequence also shows how this DNA methyltransferase inhibitor can be used to investigate stable metastatic dormancy rather than proliferation alone.

• Aclacinomycin A for DNA Damage Assays

  2026-09-03

  Aclacinomycin A (Aclarubicin) provides a practical way to connect topoisomerase stress with DNA damage, apoptosis, and nucleolar remodeling in cancer-cell assays. This workflow combines concentration-ranging, time-resolved readouts, and PML-nucleolar analysis to distinguish repair-associated stress from terminal cytotoxicity.

7995 records 1/533 page Next 12345 下5页 Last page